Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC232

Brexpíprasól eða salt þar af

  • Status:
    Veitt
  • Application date:
    14.8.2018
  • Application published:
    15.9.2018
  • Grant published:
    15.11.2020
  • Max expiry date:
    11.4.2031
  • Next due date:
    30.4.2027
  • Medicine name:
    RXULTI
  • Medicine for children:
    No

Timeline

Today
14.8.2018Application
15.9.2018Publication
15.11.2020Registration
30.4.2027Expires

Marketing license

  • IS authorization number:
    EU/1/18/1294/001-007
  • Date:
    21.8.2018
  • Foreign authorization number:
    EU/1/18/1294
  • Date:
    26.7.2018

Owner

  • Name:
    OTSUKA PHARMACEUTICAL CO., LTD.
  • Address:
    9, Kanda-Tsukasacho 2-chome, Chiyoda-ku, Tokyo JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 20.4.2026

Expires: 30.4.2027

Payer: Árnason Faktor ehf.

Upload documents